Metabolic-Fit / 100
Zealthy review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
FDA warning letter #716501 (Sept. 2025), which names Zealthy's website, and in April 2026 the FTC and DOJ moved to seize the company and freeze its assets. Read both before anything else here. Semaglutide: Medication from $151/mo; total program cost requires confirmation; tirzepatide: Current public tirzepatide cash total not itemized. The medication sticker does not establish total program cost, and no current tirzepatide cash total is itemized publicly.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
Zealthy at a glance
- Semaglutide
- Total price unconfirmed; medication advertised from $151/mo
- Tirzepatide
- Current public tirzepatide cash total not itemized
- Coverage
- Most states
- Brand-name
- Compounded only
How we scored Zealthy
Every factor comes from Zealthy's own published pricing, disclosures and oversight, and the six combine into the 33/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
FDA warning letter #716501 (Sept. 2025), which names Zealthy's website, and in April 2026 the FTC and DOJ moved to seize the company and freeze its assets. Read both before anything else here. Semaglutide: Medication from $151/mo; total program cost requires confirmation; tirzepatide: Current public tirzepatide cash total not itemized. The medication sticker does not establish total program cost, and no current tirzepatide cash total is itemized publicly.
Before you sign up
What Zealthy's public site and signup page show before you hand over any details.
Worth knowing
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $151 | Public medication starting rateDo not treat as total treatment cost: required program/membership costs and working-dose conditions were not fully itemized. Insured $25 brand copay is eligibility-dependent. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Zealthy's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Semaglutide: Medication from $151/mo; total program cost requires confirmation; tirzepatide: Current public tirzepatide cash total not itemized.
The caveats
- No dedicated postpartum, breastfeeding, or PCOS framing
- April 2026: the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation and review manipulation
- The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent — the government's words are that Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts". These are allegations, not findings; the case is ongoing
- Separately, and earlier: FDA warning letter #716501, dated September 9, 2025, to FitRX, LLC dba Zealthy, over the unlawful sale of unapproved and misbranded compounded semaglutide — the letter names Zealthy's website
- The same operator, FitRX, LLC, holds two further FDA warning letters under other trading names — #717987 (20 February 2026, dba FitRx, naming another website) and #728275 (8 June 2026, dba AM RX, naming another website). Neither names Zealthy's website, so neither is this storefront's own letter; both are recorded here because they are the same legal entity
- Compounded only — not an FDA-approved finished product
- The medication sticker does not establish total program cost, and no current tirzepatide cash total is itemized publicly.
Zealthy: listed only so a reader can see why it ranks last
Zealthy currently advertises semaglutide medication from $151 per month without insurance, alongside eligibility-dependent brand copays from $25. Required program charges and a current tirzepatide cash total are not fully itemized on the public pages, so neither figure establishes the complete ongoing cost. Read the regulatory context below before choosing a program.
The FTC and DOJ receivership petition
In April 2026 the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation practices, and review manipulation. The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent. In the government's own words, Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts." These are allegations, not adjudicated findings, and the case remains open. They are also serious enough that a mother evaluating this provider should read the filing herself before signing up for anything.
A separate, earlier FDA warning letter
Before the federal receivership action, Zealthy carried its own regulatory history: an FDA warning letter dated 9 September 2025, addressed to FitRX, LLC dba Zealthy and naming Zealthy's website, over the unlawful sale of unapproved and misbranded compounded semaglutide. That letter and the 2026 FTC/DOJ action are two separate matters, both attached to the same company, months apart.
What the low price does not tell a mother
Zealthy advertises both compounded medication and access to branded GLP-1s. Program fees can move the complete cost above a medication sticker or insured copay, and its current public pages do not establish an unconditional all-inclusive monthly price. Confirm the treatment, required care charges and renewal terms together before comparing a quote with other providers.
Why we still publish a review of a company under federal action
A mother searching for Zealthy by name deserves to find what a regulator found, not a gap where a review used to be. Delisting it quietly would leave the search results to third-party sites with less complete information, or to Zealthy's own marketing. Keeping the entry, with the receivership petition and the warning letter stated plainly and dated, is the more useful outcome for the reader this board exists for — even though nothing about the entry recommends starting treatment here while the case is open.
The bottom line
Zealthy stays on this board for the same reason every provider does: transparency serves a reader better than silence. It is not a recommendation. While the federal case remains open and with a September 2025 FDA warning letter on the record, a mother has better, better-documented options on this list — starting with CoreAge Rx, a featured partner.
The bottom line for mothers
Best for: Nothing, while the federal case is open. It stays on the board for transparency, not as a suggestion.
Alternatives to Zealthy
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit MadeMed46
Metabolic-Fit / 100
A flat $239/mo semaglutide, $399/mo tirzepatide with one-click cancellation and a free L-Carnitine add-on at every dose — but it's only licensed in 23 states, and most of the country's biggest population centers aren't on the list.
- Visit Collective40
Metabolic-Fit / 100
Compounded semaglutide at $59 per month and tirzepatide at $69, with a separate required $199 annual membership. Twelve medication charges plus membership total $907 or $1,027 in the first year. A 21-day membership trial precedes the annual charge; it does not promise free medication, and paid membership fees are non-refundable. The program lists 44 states, excluding Alabama, California, Louisiana, Massachusetts, Mississippi and Washington. Confirm the dispensing pharmacy and the cancellation deadlines before joining.
Providers like Zealthy
Keep comparing Zealthy
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Zealthy, answered
- How much does Zealthy cost?
- Zealthy does not establish a comparable recurring monthly medication rate. Published pricing: Total price unconfirmed; medication advertised from $151/mo for semaglutide; Current public tirzepatide cash total not itemized for tirzepatide. Ask for the complete charge, supply period and renewal terms before committing.
- Is Zealthy safe to use while breastfeeding?
- None of these drugs is established as safe in pregnancy, so stopping before you try to conceive is the usual plan. Nursing is less clear-cut. The Wegovy injection and Ozempic labels have little or no breast-milk data and ask you and your clinician to weigh the benefits of breastfeeding against how much you need the drug. Compounded versions carry no label of their own; ask the prescriber directly how they handle nursing patients. Zealthy is not an exception to any of that — settle the timing with your own clinician.
- Does Zealthy offer both semaglutide and tirzepatide?
- Zealthy's tirzepatide access isn't consistently disclosed; it's primarily a semaglutide program as last verified. If you specifically want tirzepatide, confirm availability first.
- How does Zealthy score for mothers?
- Zealthy scores 33/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect Zealthy's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.